Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Star
6436.5000 -49.00 (-0.76%)
NSE Jan 13, 2026 15:31 PM
Volume: 253.7K
 

6436.50
-0.76%
Axis Direct
While Q3 EBITDA was inline with estimate, PAT of Rs 2.68bn was 10% below our estimate due to higher taxes. Revenue growth was muted at 13% YoY (9M was 14% YoY, 10% in cc terms). Divi'sguided for 10- 15% cc revenue growth for FY17/18 vs.15% earlier, given delay in adding capacities (Vizagand Kakina..
Divi's Laboratories Ltd. is trading above its 200 day SMA of 6339.0
More from Divi's Laboratories Ltd.
Recommended